Indonesia vs South Africa: Proportion of the target population who received the final dose of
Indonesia
79.0%
in 2024
South Africa
79.0%
in 2024
Indonesia rank
24th
South Africa rank
24th
Proportion of the target population who received the final dose of over time
- Indonesia
- South Africa
How they compare
Indonesia currently reports 79.0% against 79.0% in South Africa, a difference of 0.0%.
The two have swapped places 2 times across 8 shared years of data; in 2017 it was South Africa ahead.
Indonesia ranks 24th and South Africa ranks 24th of 107 countries.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.7% | 47.3% | 44.7% | South Africa |
| 2020s | 24.6% | 47.0% | 22.4% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Indonesia or South Africa?
- Indonesia, at 79.0% against 79.0% in South Africa as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Indonesia and South Africa?
- 0.0%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and South Africa?
- 8 years are reported by both, from 2017 to 2024.
- How do Indonesia and South Africa rank globally for proportion of the target population who received the final dose of?
- Indonesia ranks 24th and South Africa ranks 24th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.